Insights

CBD May Be Available Behind The Counter By 2021

Published by External Author,
20, May

The Department of Health has proposed that CBD is made available behind the counter via a pharmacist. This means making low dose CBD oil a Schedule III drug. Find out what this means for Australian consumers, patients and the Australian cannabis industry.

The Australian CBD market is drastically different from those overseas, particularly the USA and Canada. Part of the reason rescheduling CBD is being explored is because of increasing interest and demand, globally, for access to these sorts of products without a prescription.

In this interview, honahlee founder, Tom Brown speaks with cannabis expert Rhys Cohen about what the proposed rescheduling of CBD means and how you can have a say in the Department of Health review. View the interview here: https://www.youtube.com/watch?v=AslPxc36ZxY&feature=youtu.be

Read the full article by Tom Brown here: https://honahlee.com.au/articles/cannabidiol-schedule-4-to-3/

You might also be interested in

Insights

What legal cannabis in Canada means for science

Published by External Author.

17 Oct

Insights

Asia plants seeds for medical cannabis market

Published by External Author.

04 Nov

View all articles